[Federal Register Volume 66, Number 106 (Friday, June 1, 2001)]
[Notices]
[Page 29822]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-13908]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. 01N-0078]


Agency Information Collection Activities; Proposed Collections; 
Reopening of Comment Period; Direct-to-Consumer Promotion of 
Prescription Drugs

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice; Reopening of comment period.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA) is reopening the 
comment period to June 5, 2001, the comment period for the two proposed 
collections of certain information by the agency. This notice reopens 
the comment period on surveys of physicians and patients to examine the 
impact of direct-to-consumer (DTC) promotion of prescription drugs. The 
purpose of the proposed information collection is to followup on the 
agency's 1999 patient survey and expand information collection to 
include physicians.

DATES: Submit written or electronic comments on the collection of 
information by June 5, 2001.

ADDRESSES: Submit electronic comments on the collection of information 
to: http://www.accessdata.fda.gov/scripts/oc/dockets/edockethome.cfm. 
Submit written comments by June 5, 2001, on the collection of 
information to the Dockets Management Branch (HFA-305), Food and Drug 
Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. All 
comments should be identified with the docket number found in brackets 
in the heading of this document.

FOR FURTHER INFORMATION CONTACT: Karen Nelson, Office of Information 
Resources Management (HFA-250), Food and Drug Administration, 5600 
Fishers Lane, Rockville, MD 20857, 301-827-1482.

SUPPLEMENTARY INFORMATION: FDA needs information from physicians and 
patients about their reactions to, and behaviors that stem from, DTC 
prescription drug advertising in order to develop policy on appropriate 
requirements for regulating drug product promotional materials. The 
agency is reopening the comment period for the proposed collections due 
to technical problems encountered on the electronic comment submission 
site during the previous comment period.

    Dated: May 29, 2001.
Margaret M. Dotzel,
Associate Commissioner for Policy.
[FR Doc. 01-13908 Filed 5-30-01; 11:29 am]
BILLING CODE 4160-01-S